Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Calis, Job C J ^a,b   Rotteveel, Hellen P ^c   van der Kuyl, Antoinette C ^c   Zorgdrager, Fokla ^c   Kachala, David ^b   van Hensbroek, Michaël I ^a,b,d   Cornelissen, Marion ^c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY OF MALAWI   (Malawi)

^c Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEIC ACID; VIRUS ENVELOPE PROTEIN; CHEMOKINE RECEPTOR CXCR4; PRIMER DNA;

AMINO ACID SEQUENCE; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOME SIZE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; MALAWI; MALE; MOLECULAR PHYLOGENY; NONHUMAN; PATIENT MONITORING; PRESCHOOL CHILD; PROTEIN GLYCOSYLATION; STRAIN DIFFERENCE; VERTICAL TRANSMISSION; VIRUS GENE; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN; BLOOD; CLASSIFICATION; CROSS-SECTIONAL STUDY; ENVELOPE GENE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MORTALITY; NEWBORN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; VIROLOGY;

ANEMIA; BONE MARROW; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA PRIMERS; FEMALE; FOLLOW-UP STUDIES; GENES, ENV; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MALAWI; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRES; RECEPTORS, CXCR4;

EID: 42449096377     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-26     Document Type: Article

References (52)

1. Zon LI Arkin C Groopman JE: Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol 1987, 66:251-256. 10.1111/ j.1365-2141.1987.tb01307.x 3606961
2. Ellaurie M Burns ER Rubinstein A; Hematologic manifestations in pediatric HIV infection: Severe anemia as a prognostic factor. Am J Pediatr Hematol Oncol 1990, 12:449-453. 2285125
3. Moses A Nelson J Bagby GC Jr: The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998, 91:1479-1495. 9473211
4. Bain BJ: The haematological features of HIV infection. Br J Haematol 1997, 99:1-8. 10.1046/j.1365-2141.1997.2943111.x 9359495
5. Moore RD Keruly JC Chaisson RE: Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:29-33. 9732065
6. Bain BJ: Pathogenesis and pathophysiology of anemia in HIV infection. Curr Opin Hematol 1999, 6:89-93. 10.1097/00062752-199903000-00006 10088638
7. Gibellini D Re MC Vitone F Rizzo N Maldini C La PM: Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein. Clin Exp Immunol 2003, 131:428-435. 1808660 12605695 10.1046/j.1365-2249.2003.02095.x
8. Zauli G Vitale M Re MC Furlini G Zamai L Falcieri E: In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood 1994, 83:167-175. 7506078
9. Casper CH Clevestig P Carlenor E Leitner T Anzen B Lidman K: Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. J Infect Dis 2002, 186:914-921. 10.1086/342948 12232831
10. Connor RI Sheridan KE Ceradini D Choe S Landau NR: Change in coreceptor use coreceptor use correlates with disease progression in HIV-1 - infected individuals. J Exp Med 1997, 185:621-628. 10.1084/jem.185.4.621 9034141
11. Scarlatti G Tresoldi E Bjorndal A Fredriksson R Colognesi C Deng HK: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997, 3:1259-1265. 10.1038/ nm1197-1259 9359702
12. Tersmette M Lange JM de Goede RE de WF Eeftink-Schattenkerk JK Schellekens PT: Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989, 1:983-985. 10.1016/S0140-6736(89)92628-7 2565516
13. Majka M Ratajczak J Lee B Honczarenko M Douglas R Kowalska MA The role of HIV-related chemokine receptors and chemokines in human erythropoiesis in vitro Stem Cells 2000 18 128 138 10.1634/ stemcells.18-2-128 10742385
14. Aiuti A Turchetto L Cota M Cipponi A Brambilla A Arcelloni C: Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 1999, 94:62-73. 10381499
15. Voulgaropoulou F Pontow SE Ratner L; Productive infection of CD34+ -cell-derived megakaryocytes by X4 and R5 HIV-1 isolates. Virology 2000, 269:78-85. 10.1006/viro.2000.0193 10725200
16. Rozmyslowicz T Majka M Kijowski J Murphy SL Conover DO Poncz M: Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 2003, 17:33-42. 10.1097/00002030-200301030-00006 12478067
17. Vlahakis SR Geciras-Schimnich A Bou G Heppelmann CJ Villasis-Keever A Collman RC: Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest 2001, 107:207-215. 199176 11160137 10.1172/JCI11109
18. Mocroft A Kirk O Barton SE Dietrich M Proenca R Colebunders R: Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 1999, 13:943-950. 10.1097/00002030-199905280-00010 10371175
19. Sullivan PS Hanson DL Chu SY Jones JL Ward JW: Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91:301-308. 9414298
20. Cilliers T Nhlapo J Coetzer M Orlovic D Ketas T Olson WC: The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C. J Virol 2003, 77:4449-4456. 150635 12634405 10.1128/JVI.77.7.4449-4456.2003
21. De Jong JJ De RA Keulen W Tersmette M Goudsmit J: Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J Virol 1992, 66:6777-6780. 240176 1404617
22. Fouchier RA Groenink M Kootstra NA Tersmette M Huisman HG Miedema F: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66:3183-3187. 241084 1560543
23. Fouchier RA Brouwer M Broersen SM Schuitemaker H: Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J Clin Microbiol 1995, 33:906-911. 228065 7790458
24. Hartley O Klasse PJ Sattentau QJ Moore JP: V3: HIV's switch-hitter. AIDS Res Hum Retroviruses 2005, 21:171-189. 10.1089/aid.2005.21.171 15725757
25. Jensen MA Coetzer M van't Wout AB Morris L Mullins JI: A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006, 80:4698-4704. 1472078 16641263 10.1128/JVI.80.10.4698-4704.2006
26. Jensen MA Li FS van't Wout AB Nickle DC Shriner D He HX: Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol 2003, 77:13376-13388. 296044 14645592 10.1128/ JVI.77.24.13376-13388.2003
27. Jensen MA van't Wout AB; Predicting HIV-1 coreceptor usage with sequence analysis. AIDS Rev 2003, 5:104-112. 12876899
28. Resch W Hoffman N Swanstrom R: Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks 2. Virology 2001, 288:51-62. 10.1006/ viro.2001.1087 11543657
29. Coetzer M Cilliers T Papathanasopoulos M Ramjee G Karim SA Williamson C: Longitudinal Analysis of HIV Type 1 Subtype C Envelope Sequences from South Africa. AIDS Res Hum Retroviruses 2007, 23:316-321. 10.1089/ aid.2006.0207 17331039
30. Pollakis G Kang S Kliphuis A Chalaby MI Goudsmit J Paxton WA: N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001, 276:13433-13441. 10.1074/jbc.M009779200 11278567
31. Pollakis G Abebe A Kliphuis A Chalaby MI Bakker M Mengistu Y: Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals. J Virol 2004, 78:2841-2852. 353763 14990703 10.1128/JVI.78.6.2841-2852.2004
32. Cao J Sullivan N Desjardin E Parolin C Robinson J Wyatt R: Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol 1997, 71:9808-9812. 230295 9371651
33. Pinter A Honnen WJ He Y Gorny MK Zolla-Pazner S Kayman SC: The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J Virol 2004, 78:5205-5215. 400352 15113902 10.1128/JVI.78.10.5205-5215.2004
34. Sagar M Wu X Lee S Overbaugh J: Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J Virol 2006, 80:9586-9598. 1617272 16973562 10.1128/JVI.00141-06
35. Wei X Decker JM Wang S Hui H Kappes JC Wu X: Antibody neutralization and escape by HIV-1. Nature 2003, 422:307-312. 10.1038/nature01470 12646921
36. Groenink M Fouchier RA Broersen S Baker CH Koot M van't Wout AB: Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993, 260:1513-1516. 10.1126/science.8502996 8502996
37. Jansson M Backstrom E Scarlatti G Bjorndal A Matsuda S Rossi P: Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2001, 17:1405-1414. 10.1089/088922201753197079 11679153
38. Calis JCJ Phiri KS Faragher EB Brabin BJ Bates I Cuevas LE: Factors associated with severe anemia in Malawian children. N Engl J Med 2007. 17878150
39. Dibley MJ Goldsby JB Staehling NW Trowbridge FL: Development of normalized curves for the international growth reference: Historical and technical considerations. Am J Clin Nutr 1987, 46:736-748. 3314468
40. WHO: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, World Health Organization 2006 19-1-0007. Ref Type: Internet Communication
41. Boom R Sol C Beld M Weel J Goudsmit J Wertheim-van DP: Improved silica-guanidiniumthiocyanate DNA isolation procedure based on selective binding of bovine alpha-casein to silica particles. J Clin Microbiol 1999, 37:615-619. 84491 9986822
42. ThompIon JD Higgins DG Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680. 308517 7984417 10.1093/nar/22.22.4673
43. The Los Alamos HIV sequence database 2007 http://www.hiv.lanl.gov
44. Kasturi L Eshleman JR Wunner WH Shakin-Eshleman SH: The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein. J Biol Chem 1995, 270:14756-14761. 10.1074/ jbc.270.24.14756 7782341
45. Online C-PSSM predictor by MA Jenssen 2007 http://mullinslab.microbiol.washington.edu/computing/pssm Ref Type: Electronic Citation
46. Wilbe K Casper C Albert J Leitner T: Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses 2002, 18:849-856. 10.1089/08892220260190326 12201907
47. Brabin BJ Premji Z Verhoeff F: An analysis of anemia and child mortality. J Nutr 2001, 131:636S-645S. 11160595
48. Biggar RJ Janes M Pilon R Roy R Broadhead R Kumwenda N: Human immunodeficiency virus type 1 infection in twin pairs infected at birth. J Infect Dis 2002, 186:281-285. 10.1086/341453 12134267
49. Travers SA Clewley JP Glynn JR Fine PE Crampin AC Sibande F: Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1. J Virol 2004, 78:10501-10506. 516391 15367616 10.1128/JVI.78.19.10501-10506.2004
50. Wilbe K Casper C Albert J Leitner T: Identification of two CRF11-cpx genomes and two preliminary representatives of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses 2002, 18:849-856. 10.1089/08892220260190326 12201907
51. Johnston ER Zijenah LS Mutetwa S Kantor R Kittinunvorakoon C Katzenstein DA: High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. J Virol 2003, 77:7682-7688. 164829 12805470 10.1128/JVI.77.13.7682-7688.2003
52. Ping LH Nelson JA Hoffman IF Schock J Lamers SL Goodman M: Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants. J Virol 1999, 73:6271-6281. 112705 10400718